Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Evanson Jeff
CHIEF COMMERCIAL OFFICER at Outlook Therapeutics. Filing since 12 Feb 2021.
CIK 0001760511
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
7 Mar 2024
CHIEF COMMERCIAL OFFICER
Bought
62,484
$26.24K
8.4%
OTLK
Outlook Therapeutics, Inc.
20 Jan 2023
Chief Commercial Officer
Sold, plan not stated
267,000
$296.37K
26.4%
OTLK
Outlook Therapeutics, Inc.
19 Jan 2023
Chief Commercial Officer
Sold, plan not stated
103,255
$125.97K
9.3%
OTLK
Outlook Therapeutics, Inc.
18 Jan 2023
Chief Commercial Officer
Sold, plan not stated
33,738
$42.17K
2.9%
OTLK
Outlook Therapeutics, Inc.
17 Jan 2023
Chief Commercial Officer
Sold, plan not stated
27,162
$35.58K
2.3%
OTLK
Outlook Therapeutics, Inc.
3 Dec 2021
Chief Commercial Officer
Bought
35,200
$47.17K
3.1%
OTLK
Outlook Therapeutics, Inc.
23 Feb 2021
Chief Commercial Officer
Sold, plan not stated
8,554
$17.86K
0.7%
OTLK
Outlook Therapeutics, Inc.
12 Feb 2021
Chief Commercial Officer
Sold, plan not stated
56,973
$145.28K
4.7%
8 decisions on file.
